For PCOS management, the enhanced weight loss with tirzepatide is especially important, as excess weight often worsens insulin resistance
This guide walks through every step and the red flags to avoid
Zepbound and NAION | Free Case Evaluation | (855) 846 6529 Clinical studies have found that patients with type 2 diabetes who had no prior eye disorders, and were prescribed Zepbound (tirzepatide) had an increased risk of developing NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy)
Combining weight loss with other treatments can enhance your overall wellness and appearance
A substance can still affect treatment planning even when it is not strictly forbidden
Participants with BMI under 35 had higher dropout rates, sometimes due to perceived excessive weight loss. For participants with BMI 35 (the primary target population for this medication), discontinuation rates were 8.8-12.1%, more comparable to other weight loss medications